JP2024001073A5 - - Google Patents

Download PDF

Info

Publication number
JP2024001073A5
JP2024001073A5 JP2023165289A JP2023165289A JP2024001073A5 JP 2024001073 A5 JP2024001073 A5 JP 2024001073A5 JP 2023165289 A JP2023165289 A JP 2023165289A JP 2023165289 A JP2023165289 A JP 2023165289A JP 2024001073 A5 JP2024001073 A5 JP 2024001073A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
antibody
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023165289A
Other languages
English (en)
Japanese (ja)
Other versions
JP7849340B2 (ja
JP2024001073A (ja
Filing date
Publication date
Priority claimed from JP2020543460A external-priority patent/JP7358367B2/ja
Application filed filed Critical
Priority to JP2023165289A priority Critical patent/JP7849340B2/ja
Publication of JP2024001073A publication Critical patent/JP2024001073A/ja
Publication of JP2024001073A5 publication Critical patent/JP2024001073A5/ja
Application granted granted Critical
Publication of JP7849340B2 publication Critical patent/JP7849340B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023165289A 2017-10-24 2023-09-27 抗グリコmuc1抗体およびその使用 Active JP7849340B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023165289A JP7849340B2 (ja) 2017-10-24 2023-09-27 抗グリコmuc1抗体およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020543460A JP7358367B2 (ja) 2017-10-24 2017-10-24 抗グリコmuc1抗体およびその使用
PCT/US2017/058036 WO2019083506A1 (en) 2017-10-24 2017-10-24 ANTI-GLYCO-MUC1 ANTIBODIES AND USES THEREOF
JP2023165289A JP7849340B2 (ja) 2017-10-24 2023-09-27 抗グリコmuc1抗体およびその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020543460A Division JP7358367B2 (ja) 2017-10-24 2017-10-24 抗グリコmuc1抗体およびその使用

Publications (3)

Publication Number Publication Date
JP2024001073A JP2024001073A (ja) 2024-01-09
JP2024001073A5 true JP2024001073A5 (https=) 2024-04-24
JP7849340B2 JP7849340B2 (ja) 2026-04-21

Family

ID=66247577

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020543460A Active JP7358367B2 (ja) 2017-10-24 2017-10-24 抗グリコmuc1抗体およびその使用
JP2023165289A Active JP7849340B2 (ja) 2017-10-24 2023-09-27 抗グリコmuc1抗体およびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020543460A Active JP7358367B2 (ja) 2017-10-24 2017-10-24 抗グリコmuc1抗体およびその使用

Country Status (10)

Country Link
EP (1) EP3700936A4 (https=)
JP (2) JP7358367B2 (https=)
KR (2) KR102608763B1 (https=)
CN (1) CN111479828B (https=)
AU (1) AU2017436815B2 (https=)
BR (1) BR112020008001A2 (https=)
CA (1) CA3078812A1 (https=)
IL (1) IL274202A (https=)
MX (1) MX2020004220A (https=)
WO (1) WO2019083506A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020004220A (es) * 2017-10-24 2020-10-05 Go Therapeutics Inc Anticuerpos anti-glico-muc1 y sus usos.
BR112023001739A2 (pt) * 2020-07-31 2023-02-28 Scherer Technologies Llc R P Anticorpo específico para mucina-1 e métodos de uso do mesmo
JP2024534148A (ja) * 2021-08-27 2024-09-18 ペプトロン インコーポレイテッド 新規抗muc1抗体およびその用途
AU2022420709A1 (en) * 2021-12-21 2024-08-01 Merus B.V. Binding domains against cancer-associated muc1
CN114099685B (zh) * 2022-01-27 2022-06-21 中国农业大学 抑制muc1表达和糖基化修饰的物质在降低抗乳腺癌药物耐药性中的应用
CN120882753A (zh) * 2023-04-13 2025-10-31 江苏恒瑞医药股份有限公司 特异性结合egfr和muc1的抗原结合分子、其药物偶联物及其医药用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075110A2 (en) * 2000-03-30 2001-10-11 Dyax Corp. Mucin-1 specific binding members and methods of use thereof
DE10303664A1 (de) * 2003-01-23 2004-08-12 Nemod Immuntherapie Ag Erkennungsmoleküle zur Behandlung und Detektion von Tumoren
EP2083868A2 (en) * 2006-10-04 2009-08-05 Københavns Universitet Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies
EP2014302A1 (en) * 2007-07-12 2009-01-14 Institut Curie An antibody specific for the Tn antigen for the treatment of cancer
JP5532401B2 (ja) * 2007-12-05 2014-06-25 協和発酵キリン株式会社 ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体
JP5773352B2 (ja) * 2008-10-28 2015-09-02 塩野義製薬株式会社 抗muc1抗体
EP2281844A1 (en) * 2009-07-31 2011-02-09 Glycotope GmbH MUC 1 antibodies
US10208125B2 (en) * 2013-07-15 2019-02-19 University of Pittsburgh—of the Commonwealth System of Higher Education Anti-mucin 1 binding agents and uses thereof
US20170145108A1 (en) * 2014-02-05 2017-05-25 The University Of Chicago Chimeric antigen receptors recognizing cancer-specific tn glycopeptide variants
AU2015254257B2 (en) * 2014-04-28 2021-02-25 Medicinal Chemistry Pharmaceuticals, Co., Ltd. Anti-MUC1 antibody or antigen-binding fragment of same, and use thereof
MX2020004220A (es) 2017-10-24 2020-10-05 Go Therapeutics Inc Anticuerpos anti-glico-muc1 y sus usos.

Similar Documents

Publication Publication Date Title
JP2024001073A5 (https=)
EP4039707A1 (en) Cd3-targeting antibody, bispecific antibody and use thereof
EP3353213B1 (en) Anti-mesothelin antibody and composition comprising the same
JP2019116474A5 (https=)
AU2020352382A1 (en) Anti-human claudin 18.2 antibody and application thereof
JP2021510710A5 (https=)
JP2019527553A5 (https=)
JP2021503455A5 (https=)
AU2018218753A1 (en) Anti-GPRC5D antibody and molecule containing same
JP2013502913A5 (https=)
JPWO2020114480A5 (https=)
KR20220111308A (ko) 인간화 cldn18.2 항체
AU2017379382A1 (en) Anti-CD3 Antibody and Molecules Comprising the Antibody
EP4155320A1 (en) Anti-b7h4 antibody, and bispecific antibody and use thereof
TW202241944A (zh) 新穎的抗gremlin1抗體
JP2020522488A5 (https=)
CN106243223B (zh) 抗人pdl1抗体及其用途
CN113574069A (zh) 抗pd-l1抗体及其用途
JP2021529524A5 (https=)
US12577314B2 (en) Anti-BCMA/anti-4-1BB bispecific antibodies and uses thereof
JPWO2019185040A5 (https=)
CN112805297B (zh) 抗人类pd-l1抗体及其用途
JPWO2022104236A5 (https=)
JPWO2022159984A5 (https=)
JPWO2022068854A5 (https=)